한글목차

세계 바이오칩 시장 규모는 2024년 161억 달러에서 2024년부터 2029년까지 CAGR 11.6%로 성장하여 2029년에는 278억 달러에 달할 것으로 예상됩니다.

바이오칩 기기 및 소프트웨어 시장은 2024년 68억 달러에서 CAGR 11.3%로 성장하여 2029년에는 116억 달러에 달할 것으로 예상됩니다. 미세유체 바이오칩(랩온칩) 시장은 2024년 25억 달러에서 CAGR 12.6%로 성장하여 2029년에는 46억 달러에 달할 것으로 추정됩니다.

세계의 바이오칩 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약

제2장 시장 개요

• 개요·시장 정의
• 기술적 배경
• 기술 인프라와 데이터 통합

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• POC(Point of Care) 진단 수요 증가
• 바이오칩과 마이크로어레이 조사에 대한 투자와 자금 증가
• 암 이환율 증가에 의한 맞춤형 치료 수요 증가
• 시장 성장 억제요인과 과제
• 바이오칩 기술 개발과 도입에 따른 고비용
• 기술적 과제
• 시장 기회
• 바이오칩 업계의 기술 진보와 자동화
• 임상 연구 증가

제4장 규제 상황

• 시장 규제 : 기관별
• 미국
• 연방 규제
• CMS 규제
• FDA 규제
• FTC 규제
• 캐나다
• EU
• 영국
• 중국
• 일본
• 호주
• 국제 기준과 가이드라인

제5장 신기술과 개발

• 바이오 의료에서 바이오칩 기술에 AI 적용
• DNA 및 단백질 마이크로어레이의 발전
• 3D 마이크로어레이와 오가노이드 온칩
• 하이드로겔 기반 마이크로어레이
• 다른 종류의 3D 마이크로어레이

제6장 시장 세분화 분석

• 시장 개요
• 세분화 내역
• 세계의 바이오칩 시장 : 제품별
• 마이크로어레이(어레이 기반 바이오칩)
• 미세유체 바이오칩(랩온어칩)
• 바이오칩 기기 및 소프트웨어
• 바이오칩 소모품 및 키트
• 세계의 바이오칩 시장 : 기술별
• 마이크로어레이 기술
• 미세유체 기술
• 세계의 바이오칩 시장 : 용도별
• 유전체학
• 단백질체학
• 질병 진단
• 의약품 발견과 개발
• 세계의 바이오칩 시장 : 최종사용자별
• 학술연구기관
• 바이오의약품 기업
• 병원·진단 센터
• 지역적 내역
• 세계의 바이오칩 시장 : 지역별
• 시장 규모와 예측
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제7장 경쟁 정보

• 업계 구조
• 획기적 기술과 제품 발매
• 주요 기업 순위
• 기업이 채용하고 있는 주요 전략
• 제휴·협력
• 신제품 발매
• 확대와 투자
• M&A

제8장 바이오칩 시장의 지속가능성 : ESG 관점

• ESG : 소개
• 바이오칩 시장의 ESG 퍼포먼스
• 바이오칩 업계의 ESG 실천
• 환경 퍼포먼스
• 사회적 퍼포먼스
• 거버넌스 퍼포먼스
• ESG 리스크 평가
• BCC에 의한 결론

제9장 부록

• 조사 방법
• 약어
• 기업 개요
• ABBOTT
• AGILENT TECHNOLOGIES INC.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• F. HOFFMANN-LA ROCHE LTD.
• IBIOCHIPS
• ILLUMINA INC.
• LI-COR BIOTECH LLC.
• MICRONIT B.V.
• NUTCRACKER THERAPEUTICS INC.
• QIAGEN
• RANDOX LABORATORIES LTD.
• REVVITY
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

The biochip equipment and software market for biochip was valued at $6.8 billion in 2024 and is estimated to reach $11.6 billion by 2029, at a CAGR of 11.3% from 2024 through 2029.

The microfluidic biochips (lab-on-a-chip) market for biochip was valued at $2.5 billion in 2024 and is estimated to reach $4.6 billion by 2029, at a CAGR of 12.6% from 2024 through 2029.

Report Scope

This report provides an overview of the global biochip market and analyzes market trends. The report includes global revenue ($ million) for the base year 2023 and estimated data for the forecast period 2024 through 2029. The market is segmented based on product type, technology, application, end user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific and Rest of the World (South America, the Middle East and Africa), focusing on major countries in these regions.

The report focuses on the significant trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking and shares of key companies in the global biochip market. There is also a dedicated section on company profiles that provides details about leading companies in the market.

The company profiles offer detailed information about business segments, financials, product portfolios and recent developments. By geographical region, the market has been segregated into North America, Europe, Asia-Pacific and the Rest of World, which includes the Middle East, Africa and South America. The North American region covers the U.S., Canada and Mexico. Europe examines Germany, the U.K., Italy, France, Spain and the Rest of Europe. Asia-Pacific encompasses China, Japan, India, Australia, South Korea and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, with estimates for 2024 and a forecast for 2025 through 2029.

Report Includes

• 76 data tables and 56 additional tables
• An analysis of the current and future global markets for biochip diagnostic products and technologies
• Analyses of global market trends, with historic revenue data from 2021 to 2024, and projected CAGRs through 2029
• Estimates of the size of and revenue prospects for the global biochip market, along with a market share analysis by product type, technology, application, end-user vertical, and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macro-economic factors
• A look at the major commercial biochip products and the future potential of each key market segment, emerging technologies, clinical trials, and other new developments
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
• Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity, venture fundings and investment outlook
• Company profiles of major players within the industry, including Abbott, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and BioMerieux

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview and Market Definition
• Technology Background
• Technological Infrastructure and Data Integration

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Demand for Point-of-Care Diagnostics
• Increasing Investment and Funding in Biochip and Microarray Research Activities
• Increasing Prevalence of Cancer Generating Demand for Personalized Treatments
• Market Restraints and Challenges
• High Costs Associated with Developing and Implementing Biochip Technology
• Technical Challenges
• Market Opportunities
• Technological Advances and Automation in the Biochip industry
• Growing Volume of Clinical Research

Chapter 4 Regulatory Landscape

• Market Regulations by Agency
• The U.S.
• Federal Regulation
• CMS Regulation
• FDA Regulation
• FTC Regulation
• Canada
• European Union
• The U.K.
• China
• Japan
• Australia
• International Standards and Guidelines

Chapter 5 Emerging Technologies and Developments

• Artificial Intelligence in Biochip Technology for Biomedicine
• Advances in DNA and Protein Microarrays
• 3D Microarrays and Organoid-on-a-Chip
• Hydrogel-Based Microarrays
• Other Types of 3D Microarrays

Chapter 6 Market Segmentation Analysis

• Market Overview
• Segmentation Breakdown
• Global Biochip Market by Product
• Microarrays (Array-Based Biochips)
• Microfluidic Biochips (Lab-on-a-Chip)
• Biochip Equipment and Software
• Biochip Consumables and Kits
• Global Biochip Market by Technology
• Microarray Technology
• Microfluidics Technology
• Global Biochip Market by Application
• Genomics
• Proteomics
• Disease Diagnostics
• Drug Discovery and Development
• Global Biochip Market by End User
• Academic and Research Institutes
• Biopharmaceutical Companies
• Hospitals and Diagnostic Centers
• Geographic Breakdown
• Global Biochip Market by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of World (ROW)

Chapter 7 Competitive Intelligence

• Industry Structure
• Breakthrough Technologies and Product Launches
• Top Company Rankings
• Key Strategies Adopted by Companies
• Collaborations and Partnerships
• New Product Launch
• Expansion and Investment
• Mergers and Acquisitions

Chapter 8 Sustainability in the Biochip Market: An ESG Perspective

• Introduction to ESG
• ESG Performance in the Biochip Market
• ESG Practices in the Biochip Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Methodology
• Abbreviations
• Company Profiles
• ABBOTT
• AGILENT TECHNOLOGIES INC.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• F. HOFFMANN-LA ROCHE LTD.
• IBIOCHIPS
• ILLUMINA INC.
• LI-COR BIOTECH LLC.
• MICRONIT B.V.
• NUTCRACKER THERAPEUTICS INC.
• QIAGEN
• RANDOX LABORATORIES LTD.
• REVVITY
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.